InvestorsHub Logo
Followers 145
Posts 27581
Boards Moderated 3
Alias Born 02/07/2004

Re: None

Tuesday, 04/28/2020 11:13:57 AM

Tuesday, April 28, 2020 11:13:57 AM

Post# of 651
The reason for today's action,
price spike on heavy volume:

For more than 20 years, Prof. Ruth Arnon - who developed the Copaxone drug for multiple sclerosis - has been working on developing a universal vaccine for influenza disease in its many varieties. Right now, when the world is facing the corona epidemic, it may receive the longing approval.
Anat Georgishgi Cohen
28.04.2020 07:06 Updated on 16:17

A year and a half ago, biochemist Prof. Ruth Arnon, bride of the Israel Prize for Medicine and former President of the National Academy of Sciences, received an editorial email from a scientific journal. The editor wanted to know if Arnon intended to attend a conference on MS that was to take place in the days that followed. Arnon, who signed with other scientists on the invention of a compound on which the drug was developed, Copaxone, announced that it would not arrive, and one of the researchers would appear in the laboratory. She did not imagine that the interest of the scientific editor was concealing an exciting story.

https://www.themarker.com/news/health/.premium-MAGAZINE-1.8802776

Above is a google translated excerpt from the article published
in The Marker
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BVXV News